Search
for
Sort by
Research 301–330 of 1000+
- Innovative strategies for the discovery of new drugs against alopecia areata: taking aim at the immune system
- New developing multiple sclerosis in a patient using tofacitinib due to alopesia areata
- Upadacitinib in concurrent Crohn's disease, atopic dermatitis and alopecia areata: A case report
- Alopecia areata – Current understanding and management
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Refractory alopecia in lupus treated with tofacitinib — a case-based review
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- Two phase III trials of baricitinib for alopecia areata: a critically appraised research paper
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review
- Real-world assessment of ritlecitinib in patients with severe alopecia areata: a 24-week multicentre retrospective study
- Relapse of Alopecia Areata Responders After Tofacitinib Withdrawal: A Retrospective Study of 59 Patients
- Alopecias in humans: biology, pathomechanisms and emerging therapies
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Alopecia areata
- Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment
- Baricitinib: A Review in Severe Alopecia Areata
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- One of the best treatments for alopecia areata remains unpublished
- Alopecia management from a comparative perspective: pharmacological and pharmaceutical insights in humans, dogs, and cats
- Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?
- Alopecia areata: current concepts
- HX17 The fortunate side effect: serendipity and therapeutic innovation in dermatology
- Diagnostic Challenges and Treatment Strategies in Neutrophilic Cicatricial Alopecias: A Narrative Review from Conventional Therapies to New Therapeutic Targets
- Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.